Information
Last updated: 08 January 2025

Ion channel disorders

Information
Andersen–Tawil Syndrome, Channelopathies, Hyperkalaemic Periodic Paralysis, Hypokalaemic Periodic Paralysis, Paramyotonia, Paramyotonia Congenita, ion channel disorders

Ion channel disorders, or channelopathies, are a group of conditions that involve dysfunctions in ion channels—integral membrane proteins regulating the flow of ions across cellular membranes. In skeletal muscle, these disorders variably produce myotonia (delayed relaxation of muscles after contraction), paramyotonia (worsening of muscle relaxation with repeated activity), weakness, or muscle hypertrophy.

Key Diagnostic Distinction: Myotonia vs. Paramyotonia

Classification of Ion Channel Disorders Affecting Skeletal Muscle

Ion channel disorders can be grouped as follows:

  1. Clinical and Neurophysiological Evidence of Myotonia:

    • Dystrophic muscle disorders: Includes myotonic dystrophy, where weakness and myotonia coexist with systemic features (e.g., cataracts, cardiac abnormalities).
    • Non-dystrophic myotonic disorders: Includes chloride and sodium channelopathies such as myotonia congenita and paramyotonia congenita. These may or may not be associated with fixed muscle weakness.
  2. Electrical Evidence of Myotonia Without Clinical Features:

    • Detected through electromyography (EMG).
    • Can be seen in genetic myopathies (e.g., certain ion channel mutations) or secondary to medication (e.g., chloroquine, statins).
  3. Suggestive Symptoms Without Clinical or Electrical Myotonia:

    • Symptoms such as stiffness or transient weakness may occur without confirmatory evidence on clinical exam or EMG.
    • Examples include episodic symptoms in periodic paralysis or secondary causes like endocrine dysfunction.

Myotonic Muscle Diseases: Features and Examples

These disorders lead to varying combinations of weakness, myotonia, and muscle hypertrophy. Brief descriptions include: